GITNUXREPORT 2025

Upskilling And Reskilling In The Pharma Industry Statistics

Pharma industry prioritizes upskilling and reskilling for innovation and competitiveness.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

66% of pharma companies are expanding their digital training programs due to accelerated technological advances

Statistic 2

55% of pharma organizations report challenges in keeping up with emerging digital tools

Statistic 3

78% of pharma companies predict that AI-driven learning platforms will become standard within the next five years

Statistic 4

45% of pharma employees reported a skills gap in digital literacy in 2023

Statistic 5

only 30% of pharma employees feel they have adequate access to reskilling opportunities

Statistic 6

59% of pharma organizations aim to reskill staff for advanced manufacturing roles within three years

Statistic 7

70% of pharma professionals believe digital upskilling will lead to better job security

Statistic 8

73% of pharma HR leaders consider reskilling to be crucial for addressing talent shortages

Statistic 9

65% of pharma employees require retraining to keep pace with new drug development technologies

Statistic 10

35% of pharma companies found it challenging to upskill staff due to lack of internal expertise

Statistic 11

70% of pharma managers believe reskilling can help meet increasing personalized medicine demands

Statistic 12

58% of pharma firms report difficulty in measuring the ROI of upskilling programs

Statistic 13

55% of pharma HR departments report difficulties in retaining reskilled workers

Statistic 14

46% of pharma companies have reported a skills shortage in digital health solutions

Statistic 15

77% of pharma executives agree that upskilling is vital for digital transformation

Statistic 16

63% of pharma companies view reskilling as essential for future workforce agility

Statistic 17

38% of pharma companies have established partnerships with tech firms for upskilling employees

Statistic 18

78% of pharmaceutical companies prioritize upskilling initiatives to stay competitive

Statistic 19

65% of pharma employers plan to increase training budgets for digital skills by 2025

Statistic 20

72% of pharma companies have launched reskilling programs targeted at manufacturing staff

Statistic 21

54% of pharma firms believe upskilling will be critical to meet future regulatory requirements

Statistic 22

68% of pharmaceutical companies increased investment in AI and data analytics training over the last two years

Statistic 23

82% of pharma companies view ongoing upskilling as a strategic imperative

Statistic 24

47% of pharma companies see employee upskilling as a way to reduce turnover

Statistic 25

60% of pharma companies are collaborating with educational institutions for upskilling initiatives

Statistic 26

55% of pharma companies have implemented e-learning platforms for continuous training

Statistic 27

48% of pharma firms have reported increased engagement after launching upskilling programs

Statistic 28

80% of pharma leaders plan to invest in virtual training and simulations

Statistic 29

67% of pharma companies are training staff in compliance and regulatory updates via digital platforms

Statistic 30

52% of pharma companies prioritize leadership development as part of reskilling efforts

Statistic 31

45% of pharma companies increase their investment in cybersecurity training for employees

Statistic 32

54% of pharma organizations are focusing on upskilling in data analytics to improve clinical trial efficiency

Statistic 33

60% of pharma professionals see AI and machine learning as essential future skills

Statistic 34

88% of pharma companies consider upskilling as a way to accelerate innovation

Statistic 35

40% of pharma companies increased hiring for digital transformation roles after upskilling initiatives

Statistic 36

74% of pharma organizations plan to develop internal training academies for skill development

Statistic 37

62% of pharma companies see upskilling as essential for adapting to remote and hybrid work models

Statistic 38

51% of pharma professionals received training on advanced bioprocessing techniques in the past year

Statistic 39

69% of pharma organizations focus on reskilling for digital marketing and sales roles

Statistic 40

53% of pharma companies have incorporated gamification into their training programs to improve engagement

Statistic 41

78% of employees in pharma believe continuous learning leads to higher job satisfaction

Statistic 42

61% of pharma companies report that upskilling contributed to faster product launches

Statistic 43

48% of pharma firms are investing in virtual reality (VR) for training and skill development

Statistic 44

67% of pharma companies report increased collaboration across departments after upskilling programs

Statistic 45

42% of pharma employees reported that upskilling improved their ability to adapt to regulatory changes

Statistic 46

54% of pharma companies have established mentorship programs in conjunction with upskilling initiatives

Statistic 47

72% of pharma workers believe reskilling opportunities improve employee morale

Statistic 48

49% of pharma companies offer financial incentives for completing upskilling programs

Statistic 49

56% of pharma leaders are investing in cross-disciplinary training to promote innovation

Statistic 50

65% of pharma R&D staff undergo ongoing training to stay current on new scientific methods

Statistic 51

54% of pharma companies have adopted microlearning modules for quick skill updates

Statistic 52

47% of pharma organizations report that upskilling has led to cost savings in training

Slide 1 of 52

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

78% of pharmaceutical companies prioritize upskilling initiatives to stay competitive
65% of pharma employers plan to increase training budgets for digital skills by 2025
45% of pharma employees reported a skills gap in digital literacy in 2023
72% of pharma companies have launched reskilling programs targeted at manufacturing staff
54% of pharma firms believe upskilling will be critical to meet future regulatory requirements
68% of pharmaceutical companies increased investment in AI and data analytics training over the last two years
only 30% of pharma employees feel they have adequate access to reskilling opportunities
82% of pharma companies view ongoing upskilling as a strategic imperative
59% of pharma organizations aim to reskill staff for advanced manufacturing roles within three years
70% of pharma professionals believe digital upskilling will lead to better job security
47% of pharma companies see employee upskilling as a way to reduce turnover
60% of pharma companies are collaborating with educational institutions for upskilling initiatives
55% of pharma companies have implemented e-learning platforms for continuous training

In an era where 78% of pharmaceutical companies prioritize upskilling to remain competitive, the industry is racing to bridge digital skills gaps, invest in cutting-edge technologies, and reshape its workforce for the future.

Digital Transformation and Technology Adoption

66% of pharma companies are expanding their digital training programs due to accelerated technological advances
55% of pharma organizations report challenges in keeping up with emerging digital tools
78% of pharma companies predict that AI-driven learning platforms will become standard within the next five years

Digital Transformation and Technology Adoption Interpretation

As the pharma industry races to embrace AI and digital tools, with 78% predicting AI-driven learning becoming standard, the 66% investing in digital training and 55% grappling with rapid technological shifts underscore a high-stakes chase to stay ahead in a biotech world that never slows down.

Employee Skills Gap and Retraining

45% of pharma employees reported a skills gap in digital literacy in 2023
only 30% of pharma employees feel they have adequate access to reskilling opportunities
59% of pharma organizations aim to reskill staff for advanced manufacturing roles within three years
70% of pharma professionals believe digital upskilling will lead to better job security
73% of pharma HR leaders consider reskilling to be crucial for addressing talent shortages
65% of pharma employees require retraining to keep pace with new drug development technologies
35% of pharma companies found it challenging to upskill staff due to lack of internal expertise
70% of pharma managers believe reskilling can help meet increasing personalized medicine demands
58% of pharma firms report difficulty in measuring the ROI of upskilling programs
55% of pharma HR departments report difficulties in retaining reskilled workers
46% of pharma companies have reported a skills shortage in digital health solutions
77% of pharma executives agree that upskilling is vital for digital transformation
63% of pharma companies view reskilling as essential for future workforce agility

Employee Skills Gap and Retraining Interpretation

With 45% of pharma employees facing a digital literacy skills gap and only 30% having adequate reskilling access, the industry is at a crossroads where urgent upskilling—embraced by 77% of executives—is not just vital for digital transformation and personalized medicine but also critical to safeguarding job security and future agility, despite internal expertise gaps and ROI measurement challenges.

Partnerships, Collaboration, and Learning Ecosystems

38% of pharma companies have established partnerships with tech firms for upskilling employees

Partnerships, Collaboration, and Learning Ecosystems Interpretation

With 38% of pharma companies teaming up with tech firms for upskilling, it's clear that the industry is recognizing that in today's digital-driven world, a healthy workforce must come with a digital edge.

Talent Development and Upskilling Initiatives

78% of pharmaceutical companies prioritize upskilling initiatives to stay competitive
65% of pharma employers plan to increase training budgets for digital skills by 2025
72% of pharma companies have launched reskilling programs targeted at manufacturing staff
54% of pharma firms believe upskilling will be critical to meet future regulatory requirements
68% of pharmaceutical companies increased investment in AI and data analytics training over the last two years
82% of pharma companies view ongoing upskilling as a strategic imperative
47% of pharma companies see employee upskilling as a way to reduce turnover
60% of pharma companies are collaborating with educational institutions for upskilling initiatives
55% of pharma companies have implemented e-learning platforms for continuous training
48% of pharma firms have reported increased engagement after launching upskilling programs
80% of pharma leaders plan to invest in virtual training and simulations
67% of pharma companies are training staff in compliance and regulatory updates via digital platforms
52% of pharma companies prioritize leadership development as part of reskilling efforts
45% of pharma companies increase their investment in cybersecurity training for employees
54% of pharma organizations are focusing on upskilling in data analytics to improve clinical trial efficiency
60% of pharma professionals see AI and machine learning as essential future skills
88% of pharma companies consider upskilling as a way to accelerate innovation
40% of pharma companies increased hiring for digital transformation roles after upskilling initiatives
74% of pharma organizations plan to develop internal training academies for skill development
62% of pharma companies see upskilling as essential for adapting to remote and hybrid work models
51% of pharma professionals received training on advanced bioprocessing techniques in the past year
69% of pharma organizations focus on reskilling for digital marketing and sales roles
53% of pharma companies have incorporated gamification into their training programs to improve engagement
78% of employees in pharma believe continuous learning leads to higher job satisfaction
61% of pharma companies report that upskilling contributed to faster product launches
48% of pharma firms are investing in virtual reality (VR) for training and skill development
67% of pharma companies report increased collaboration across departments after upskilling programs
42% of pharma employees reported that upskilling improved their ability to adapt to regulatory changes
54% of pharma companies have established mentorship programs in conjunction with upskilling initiatives
72% of pharma workers believe reskilling opportunities improve employee morale
49% of pharma companies offer financial incentives for completing upskilling programs
56% of pharma leaders are investing in cross-disciplinary training to promote innovation
65% of pharma R&D staff undergo ongoing training to stay current on new scientific methods
54% of pharma companies have adopted microlearning modules for quick skill updates
47% of pharma organizations report that upskilling has led to cost savings in training

Talent Development and Upskilling Initiatives Interpretation

As the pharmaceutical industry rapidly advances into the digital age, with over 80% of companies viewing upskilling as vital for innovation and competitiveness, it’s clear that investing in employee growth isn't just a boost in morale but a strategic move to meet regulatory hurdles, accelerate product launches, and foster cross-departmental collaboration—proving that in pharma, continuous learning isn’t optional, it’s life-saving.